Overjet vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
#1 dental AI platform for providers and payers. Founded 2018 at MIT/Harvard. $159M+ total funding, $550M valuation. Acquired DentalBee (2025). Private.
About
Overjet is the leading dental AI platform, founded in 2018 by computer scientists from MIT and dentists from Harvard, headquartered in Boston, Massachusetts. The company's FDA-cleared AI software analyzes dental X-rays in real time, helping providers detect conditions like bone loss and cavities with greater accuracy, and enabling insurance payers to automate claims review.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.